The CMA has launched a consultation on its approach to merger remedies.
The consultation follows an earlier call for evidence around three main themes: the CMA’s approach to remedies, preserving pro-competitive merger efficiencies and merger benefits, and running efficient processes.
The CMA is also making a number of changes to improve its remedies process at phase 1. This includes additional guidance for the merger parties on engaging with the CMA on remedies throughout the process, including early without-prejudice discussions on remedies.
The CMA’s consultation is open until 13 November 2025, and the final guidance is expected to be published by the end of the year.
For more information, see this post on our Competition Notes blog.
Key contacts
Gavin Davies
Partner, Head of M&A, London
Greg Mulley
Partner, London
Heidi Gallagher
Partner, London
Antonia Kirkby
Knowledge Counsel, London
Disclaimer
The articles published on this website, current at the dates of publication set out above, are for reference purposes only. They do not constitute legal advice and should not be relied upon as such. Specific legal advice about your specific circumstances should always be sought separately before taking any action.